Tamminga, Carol A.

Kv3.1-containing K channels are reduced in untreated schizophrenia and normalized with antipsychotic drugs

Yanagi, M., Joho, R. H., Southcott, S. A., Shukla, A. A., Ghose, S., & Tamminga, C. A. (2014) · Molecular Psychiatry

Schizophrenia research and treatmentIon channel regulation and function

Cited by 102

Regional alterations in RGS4 protein in schizophrenia

Erdely, H. A., Tamminga, C. A., Roberts, R. C., & Vogel, M. W. (2006) · Synapse

Schizophrenia research and treatmentReceptor Mechanisms and Signaling

Cited by 99

Amygdala Hyperactivity at Rest in Paranoid Individuals With Schizophrenia

Pinkham, A. E., Liu, P., Lu, H., Kriegsman, M., Simpson, C., & Tamminga, C. (2015) · American Journal of Psychiatry

Schizophrenia research and treatmentMental Health and Psychiatry

Cited by 93

Serum Response Factor Promotes Resilience to Chronic Social Stress through the Induction of ΔFosB

Vialou, V., Maze, I., Renthal, W., LaPlant, Q. C., Watts, E. L., Mouzon, E., Ghose, S., Tamminga, C. A., & Nestler, E. J. (2010) · The Journal of Neuroscience

Neurotransmitter Receptor Influence on BehaviorStress Responses and Cortisol

Cited by 91

ACF chromatin-remodeling complex mediates stress-induced depressive-like behavior

Sun, H., Damez-Werno, D. M., Scobie, K. N., Shao, N.-Y., Dias, C., Rabkin, J., Koo, J. W., Korb, E., Bagot, R. C., Ahn, F. H., et al. (2015) · Nature Medicine

Stress Responses and CortisolTreatment of Major Depression

Cited by 91

Conserved Higher-Order Chromatin Regulates NMDA Receptor Gene Expression and Cognition

Bharadwaj, R., Peter, C. J., Jiang, Y., Roussos, P., Vogel-Ciernia, A., Shen, E. Y., Mitchell, A. C., Mao, W., Whittle, C., Dincer, A., et al. (2014) · Neuron

Genomics and Chromatin DynamicsNeuroscience and Neuropharmacology Research

Cited by 84

Aberrant H3.3 dynamics in NAc promote vulnerability to depressive-like behavior

Lepack, A. E., Bagot, R. C., Peña, C. J., Loh, Y.-H. E., Farrelly, L. A., Lu, Y., Powell, S. K., Lorsch, Z. S., Issler, O., Cates, H. M., et al. (2016) · Proceedings of the National Academy of Sciences

Genomics and Chromatin DynamicsTreatment of Major Depression

Cited by 63

An important role for Cholecystokinin, a CLOCK target gene, in the development and treatment of manic-like behaviors

Arey, R. N., Enwright, J. F., Spencer, S. M., Falcon, E., Ozburn, A. R., Ghose, S., Tamminga, C., & McClung, C. A. (2014) · Molecular Psychiatry

Bipolar Disorder and TreatmentCircadian rhythm and melatonin

Cited by 62

Functional Connectivity of Brain Structures Correlates with Treatment Outcome in Major Depressive Disorder

Kozel, F. A., Rao, U., Lu, H., Nakonezny, P. A., Grannemann, B., McGregor, T., Croarkin, P. E., Mapes, K. S., Tamminga, C. A., & Trivedi, M. H. (2011) · Frontiers in Psychiatry

Functional Brain Connectivity StudiesTreatment of Major Depression

Cited by 61

VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine

Jiang, C., Lin, W.-J., Labonté, B., Tamminga, C. A., Turecki, G., Nestler, E. J., Russo, S. J., & Salton, S. R. (2019) · Neuropsychopharmacology

Treatment of Major DepressionNeuropeptides and Animal Physiology

Cited by 43

Setting measurement‐based care in motion: practical lessons in the implementation and integration of measurement‐based care in psychiatry clinical practice

Martin-Cook, K., Palmer, L., Thornton, L., Rush, A. J., Tamminga, C. A., & Ibrahim, H. M. (2021) · Neuropsychiatric Disease and Treatment

Psychiatric care and mental health servicesHealth Policy Implementation Science

Cited by 25

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST‐MST): study protocol for a randomized non‐inferiority trial of magnetic seizure therapy versus electroconvulsive therapy

Daskalakis, Z. J., Tamminga, C., Throop, A., Palmer, L., Dimitrova, J., Farzan, F., Thorpe, K. E., McClintock, S. M., & Blumberger, D. M. (2021) · Trials

Electroconvulsive Therapy StudiesTranscranial Magnetic Stimulation Studies

Cited by 23

A randomized, placebo-controlled proof-of-concept, crossover trial of phenytoin for hydrocortisone-induced declarative memory changes

Brown, E. S., Lu, H., Denniston, D., Uh, J., Thomas, B. P., Carmody, T. J., Auchus, R. J., Diaz-Arrastia, R., & Tamminga, C. (2013) · Journal of Affective Disorders

Stress Responses and CortisolMemory and Neural Mechanisms

Cited by 11

Autism BrainNet: A Collaboration Between Medical Examiners, Pathologists, Researchers, and Families to Advance the Understanding and Treatment of Autism Spectrum Disorder

Anderson, M. P., Quinton, R., Kelly, K., Falzon, A., Halladay, A., Schumann, C. M., Hof, P. R., Tamminga, C. A., Hare, C. K., & Amaral, D. G. (2021) · Archives of Pathology & Laboratory Medicine

Autism Spectrum Disorder ResearchAutopsy Techniques and Outcomes

Cited by 4